Your search returned the following 16 documents:

16. Peptidomimetic Escape Mechanisms Arise via Genetic Diversity in the Ligand-Binding Site of the Hepatitis C Virus NS3/4A Serine Protease
    Christoph Welsch, Tetsuro Shimakami, Christoph Hartmann, Yan Yang, Francisco S. Domingues, Thomas Lengauer, Stefan Zeuzem, and Stanley M. Lemon
    Gastroenterology 142 (3): 654-663, 2012
    
15. Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevir
    Wolf Peter Hofmann, Tje Lin Chung, Carola Osbahr, Simone Susser, Ursel Karey, Ulrike Mihm, Christoph Welsch, Jörn Lötsch, Christoph Sarrazin, Stefan Zeuzem, and Eva Herrmann
    Antiviral Therapy 16 (5): 695-704, 2011
    
14. Protease Inhibitor-Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus
    Tetsuro Shimakami, Christoph Welsch, Daisuke Yamane, David R. McGivern, MinKyung Yi, Stefan Zeuzem, and Stanley M. Lemon
    Gastroenterology 140 (2): 667-675, 2011
    
13. Dimerization of the hepatitis C virus nonstructural protein 4B depends on the integrity of an aminoterminal basic leucine zipper
    Martin-Walter Welker, Christoph Welsch, Aline Meyer, Iris Antes, Mario Albrecht, Nicole Forestier, Bernd Kronenberger, Thomas Lengauer, Albrecht Piiper, Stefan Zeuzem, and Christoph Sarrazin
    Protein Science 19 (7): 1327-1336, 2010
    
12. Effect of ribavirin on the frequency of RNAse L cleavage sites within the hepatitis C viral genome
    Ulrike Mihm, W.P. Hofmann, Christoph Welsch, A. Polta, Thomas Lengauer, Stefan Zeuzem, Christoph Sarrazin, and E. Herrmann
    Journal of Viral Hepatitis 17 (3): 217-221, 2010
    
11. HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection
    Christian Markus Lange, Kirsten Roomp, Anette Dragan, Jacob Nattermann, Monika Michalk, Ulrich Spengler, Viola Weich, Thomas Lengauer, Stefan Zeuzem, Thoma Berg, and Christoph Sarrazin
    Journal of Hepatology 53 (6): 1022-1028, 2010
    
10. Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients.
    Simone Susser, Christoph Welsch, Yalan Wang, Markus Zettler, Francisco S. Domingues, Ursula Karey, Eric Hughes, Robert Ralston, Xiao Tong, Eva Herrmann, Stefan Zeuzem, and Christoph Sarrazin
    Hepatology 50 (6): 1709-1718, 2009
    
9. Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C
   Ulrike Mihm, Oliver Ackermann, Christoph Welsch, Eva Herrmann, Wolf Peter Hofmann, Natalia Grigorian, Martin Walter Welker, Thomas Lengauer, Stefan Zeuzem, and Christoph Sarrazin
   Journal of Hepatology 50 (1): 49-58, 2009
   
8. Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of HCV
   Christoph Welsch, Francisco S. Domingues, Simone Susser, Iris Antes, Christoph Hartmann, Gabriele Mayr, Andreas Schlicker, Christoph Sarrazin, Mario Albrecht, Stefan Zeuzem, and Thomas Lengauer
   Genome Biology 9 (1): R16 p., 2008
   [PDF: Download: Welsch2008.pdf]
   
7. Correlation nonstructural (NS)4B amino acid variations with initial viral kinetics during interferon-alpha-based therapy in HCV-1b-infected patients
   Martin W. Welker, Wolf-Peter Hofmann, Christoph Welsch, Michael von Wagner, Eva Herrmann, Thomas Lengauer, Stefan Zeuzem, and Christoph Sarrazin
   Journal of Viral Hepatitis 14 (5): 338-349, 2007
   
6. Identification and in silico characterization of a novel compound heterozygosty associated with hereditary aceruloplasminemia
   Wolf Peter Hofmann, Christoph Welsch, Yoshitomo Takahashi, Hiroaki Miyajima, Ulrike Mihm, Christoph Krick, Stefan Zeuzem, and Christoph Sarrazin
   Scandinavian Journal of Gastroenterology 42 (9): 1088-1094, 2007
   
5. Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases
   Wolf Peter Hofmann, B. Fernandez, E. Herrmann, Christoph Welsch, Ulrike Mihm, B. Kronenberg, G. Feldmann, U. Spengler, Stefan Zeuzem, and Christoph Sarrazin
   Journal of Viral Hepatitis 14 (7): 484-491, 2007
   
4. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C
   Ulrike Mihm, Natalia Grigorian, Christoph Welsch, Eva Herrmann, Bernd Kronenberger, Gerlinde Teuber, Michael von Wagner, Wolf-Peter Hofmann, Mario Albrecht, Thomas Lengauer, Stefan Zeuzem, and Christoph Sarrazin
   Antiviral Therapy 11 (4): 507-519, 2006
   
3. Mutations in the MutSalpha interaction interface of MLH1 can abolish DNA mismatch repair
   Guido Plotz, Christoph Welsch, Luis Giron-Monzon, Peter Friedhoff, Mario Albrecht, Albrecht Piiper, Ricardo M. Biondi, Thomas Lengauer, Stefan Zeuzem, and Jochen Raedle
   Nucleic Acids Research 34 (22): 6574-6586, 2006
   [PDF: Download: Plotz.pdf]
   
2. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection
   Christoph Sarrazin, Ulrike Mihm, Eva Herrmann, Christoph Welsch, Mario Albrecht, Ulrike Sarrazin, Stella Traver, Thomas Lengauer, and Stefan Zeuzem
   The Journal of Infectious Diseases 192 (10): 1710-1719, 2005
   
1. Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency
   Jörg Bojunga, Christoph Welsch, Iris Antes, Mario Albrecht, Thomas Lengauer, and Stefan Zeuzem
   Human Genetics 117 (6): 558-564, 2005